for February 2018
🆕🆓🖥📚😷
— Tim Gauthier (@IDstewardship) February 20, 2018
Loving these new #antibioticstewardship modules @cdcgov just released, which includes free CEs & high-quality content. #SaveABX #Antibiotics #HealthEd #PenicillinAllergy #AdverseEffects #BadBugs https://t.co/OR2uF7htGy pic.twitter.com/DoJBN0y6Sz
Our latest BMJ #RapidRecs is out!
— ReedSiemieniuk. (@RSiemieniuk) February 6, 2018
Antibiotics after incision and drainage for skin abscesses: https://t.co/POaZt9XMI3
Lots of interesting bits of information in this one..#FOAMed #InfectiousDiseases #MRSA pic.twitter.com/KZxdFeBYIi
New Clostridium difficile guidelines released by @IDSAInfo and @SHEA_Epi for infection in adults and children. #cdiff https://t.co/y5x2kOnhC8 pic.twitter.com/T8f6gbVM6e
— IDSA (@IDSAInfo) February 15, 2018
New in CID: Infectious disease physician-led antimicrobial stewardship programs have prevented unnecessary antibiotic use, improved patient outcomes, and curbed development of drug-resistance pathogens. https://t.co/psgx7JxeAZ pic.twitter.com/P9OYqUfWw6
— IDSA (@IDSAInfo) February 12, 2018
OVIVA: Oral antibiotics non-inferior to intravenous in osteomyelitis. In our (little) ID world, a definite practice-changing study, glad to see it. https://t.co/OnoZcjXmW5
— Paul Sax (@PaulSaxMD) February 2, 2018
New online: RCT of
— The Lancet Infectious Diseases (@TheLancetInfDis) February 16, 2018
colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria https://t.co/RshVZIK4qq
New 💥💥Finally released Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).
— Antibiotic Steward (@ABsteward) February 15, 2018
https://t.co/yhQH7JlvN8 pic.twitter.com/aGfHTGYjoz
Published today! @Intermountain #SCORE study: Impact of Implementing Antibiotic Stewardship Programs in 15 Small Hospitals: A Cluster RCT. https://t.co/i36QR8DlUA
— Eddie Stenehjem (@E_Stenehjem) February 23, 2018
💥💥📢📢 According to new superiority RCT study in @TheLancetInfDis
— Antibiotic Steward (@ABsteward) February 16, 2018
The addition of meropenem to colistin did not improve clinical failure in severe Carbapenem resistant A baumannii infections. Combination therapy was not superior to monotherapy. 😱https://t.co/dGDkvedLBD pic.twitter.com/Nl6wyzTIgy
OFID: No patient harm from brief, empiric use of broad-spectrum antibiotics in the ICU for suspected infection at one large hospital. Antibiotics were usually stopped promptly once infection ruled out, a key stewardship intervention. https://t.co/KoRejpSqzU @PaulSaxMD pic.twitter.com/SPUtxzIW7V
— IDSA (@IDSAInfo) February 8, 2018
New! Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by @IDSAInfo and @SHEA_Epi #cdiff https://t.co/mL3zRBdSJn pic.twitter.com/knW0xISRdP
— SIDP (@SIDPharm) February 15, 2018
The Rise and Fall of Metronidazole for Clostridium difficile Infection - A new article in the annals of Pharmacotherapy by Dr. Elias B. Chahine. @accpinfdprn https://t.co/fwZCz4sWSP pic.twitter.com/pTIlFoSL3t
— Antibiotic Steward (@ABsteward) February 10, 2018
⭐️ NEW ⭐️ article in CMR on treatment of #ESBL, #AmpC, and #CRE infections 💊🧠https://t.co/ibi0YmbJAI@accpinfdprn @SIDPharm #AntimicrobialResistance pic.twitter.com/bL8evVLvgC
— Erin McCreary (@ErinMcCreary) February 19, 2018
Proof that antimicrobial resistance is not appreciated. In NEJM today there are the 1 millionth and 1 millionth+1 studies on steroids in sepsis. We still have no published high-quality trials examining in-hospital antimicrobial stewardship interventions. https://t.co/Od5pk7rctx
— Eli Perencevich 😷 (@eliowa) February 28, 2018
New! ID pharmacist Dr. Chahine 🗣 talks about the role of metronidazole (Flagyl) for #Cdiff and reflects on his recent 📄 publication on the topic 📲 https://t.co/lVdXoEBiRv #Cdifficile #CDAD #CDI #AbxStewardship #Antibiotic pic.twitter.com/7cHyQG6jIo
— Tim Gauthier (@IDstewardship) February 27, 2018
A new study💥 by @jpogue in @ASMicrobiology
— Antibiotic Steward (@ABsteward) February 26, 2018
An Antibiotic stewardship program blueprint for optimizing Verigene BC-GN within an institution: A tale of two cities. https://t.co/5b6EzvFJv9 pic.twitter.com/tuGrHfI9wY
#AgarArt superlative: Best Use of Texture goes to 'Bacterial endophytes celebrating the beauty of Florence' by Camilla Fagorzi, Carolina Chiellini, and Renato Fani for their B. mycoides clouds. Submit your masterpiece: https://t.co/JN6Gvu5CLl #SciArt #BioArt #microbiology pic.twitter.com/lfA7c0Vcq1
— ASM (@ASMicrobiology) February 17, 2018
Meta-analysis of short v longer antibiotic duration: SHORTER is better. Let’s make this happen https://t.co/WKfT1MMcNZ @SAPGAbx @AntibioticScot @DundasSteph @Frankerr1F @jacquisneddons @theplaguedoc
— andrew seaton (@raseaton66) February 1, 2018
New study 💥💥in cid the Impact of Implementing Antibiotic Stewardship Programs in 15 Small Hospitals: A Cluster-Randomized Intervention.
— Antibiotic Steward (@ABsteward) February 23, 2018
https://t.co/rhgt6mv5Jj pic.twitter.com/N2jVCRkIDe
New article 💥💥 in CID @SIDPharm @CDCgov Standardized Antimicrobial Administration Ratio (SAAR) : A New Metric for Measuring and Comparing Antibiotic Use. https://t.co/Sa5wYSuHEf pic.twitter.com/E2Q1J7pWu5
— Antibiotic Steward (@ABsteward) February 2, 2018
New! What is your ☝🏼 most used #antibioticstewardship resource? 📲 https://t.co/WXY2LZOhSO
— Tim Gauthier (@IDstewardship) February 21, 2018
🗣 Shout outs to @CDCgov, @AIDSinfo, @IDSAInfo, @UpToDate, @Micromedex, @wkhealth, @NebraskaMed, @JacksonHealth, and others! #SaveABX pic.twitter.com/BmES4MNon3
Bacterial aggregation in liquid culture, induced by different methods of inoculation, may impact the outcome of experiments @AppEnvMicro https://t.co/5ZVEf7eRgm pic.twitter.com/Jqdbhcnu7U
— ASM (@ASMicrobiology) February 22, 2018
Scientists discover a new class of antibiotic extracted from unknown microorganisms living in the soil.
— Microbes&Infection (@MicrobesInfect) February 13, 2018
The malacidins kill several superbugs, including methicillin-resistant #Staphylococcus aureus (#MRSA).https://t.co/6hM9c9aKGE #antibioticresistance
New study says antibiotics aren’t working for 1 out of every 5 post-surgery hospital infections. https://t.co/xxJX67QryA #antibioticresistance
— Save Antibiotics (@saveantibiotics) February 17, 2018
FDA approved expanded use of Avycaz for nosocomial pneumonia :First Gram-Negative Antibiotic Approved in the U.S. to Treat HABP/VABP in Over 15 Years@SIDPharm @accpinfdprn @IDSAInfo @IDstewardshiphttps://t.co/FZbEDKPedl
— Antibiotic Steward (@ABsteward) February 1, 2018
This #AgarArt is truly Most Frightening. 'Pennywise the scary bacterial clown' by Juliana Pachon, Valeri Saenz, and Andrés Parra uses bacteria that are resistant to last resort antibiotics. Submit your piece by 4/13: https://t.co/uXbujdWa5E #SciArt #BioArt #microbiology pic.twitter.com/T7g064UrxQ
— ASM (@ASMicrobiology) February 7, 2018
The new RCT TANGO 1 study, just published in @JAMA_current meropenem-vaborbactam is noninferior to piperacillin-tazobactam in patients with cUTIs. #vabomere https://t.co/xAQaYUPKM1 pic.twitter.com/7RCMd6Ir76
— Antibiotic Steward (@ABsteward) February 27, 2018
You’ll see a rise in diseases like tuberculosis...which is a bacteria that has become resistant to most antibiotics so not easily treated...thank Minister of Health Philpott https://t.co/SW7nnyIOkj
— Lisa Margaret (@LisaMar91564392) February 16, 2018
🏥📈📊📉😷💊
— Tim Gauthier (@IDstewardship) February 7, 2018
This is a tough topic, looking forward to reading more on #abxstewardship metrics here in @AJHPOfficial 📲 https://t.co/9zwVZk12x8 w/ @JasonGNewland & @LucasTSchulz pic.twitter.com/4MQCwfHlWx
Researchers find in soil a new antibiotic that kills several strains of multidrug-resistant bacteria, including methicillin-resistant #Staphylococcus aureus (#MRSA).#Malacidin is short for metagenomic acidic lipopeptide antibiotic-cidins.https://t.co/bmYw30hzI4
— Microbes&Infection (@MicrobesInfect) February 14, 2018
🚨New study assessing the Knowledge, Attitudes, and Practices Regarding Antimicrobial Use and Stewardship. We have a long way to go but glad to see they are open to learning. #JobSecurity https://t.co/E9jc3Wu40z pic.twitter.com/HqqhAnbIvW
— Jamie Kisgen (@KisgenUF) February 8, 2018
Bacteria share drug-resistance plasmids in chickens without drug selection. New mBiosphere story covers the #AACJournal report: https://t.co/t0PrQwYFg4 pic.twitter.com/pfr2BiCnJV
— ASM (@ASMicrobiology) February 7, 2018
Prophylactic #antibiotics for aspiration pneumonitis are not associated with clinical benefit and may ⬆️ selective pressure resulting in subsequent antibiotic escalation https://t.co/QINMNO0i2c
— Brad Langford (@BRxAD) February 11, 2018
Finally, the @IDSA & @Shea C. difficile👾 infection guidelines are updated. Check it out:https://t.co/qRdjl7hcYi pic.twitter.com/Z1xBRAdibQ
— Antibiotic Tweets (@khalideljaaly) February 15, 2018
7 versus 14 days of #antibiotic treatment for critically ill patients with bloodstream infection - pilot study published. 👏 Looking forward to seeing the final results! @CCCTG_ https://t.co/Y9SGSIEe1c
— Brad Langford (@BRxAD) February 21, 2018
Never stop learning! Take our FREE online course: 'Challenges in Antibiotic Resistance: Gram Negative Bacteria' #StopSuperbugs #AMR https://t.co/aXg2Eq9Ja1
— Antibiotic Action (@TheUrgentNeed) February 14, 2018
My brilliant supervisor Dr. Leah Cowen wrote a fantastic Op Ed in the @TorontoStar about the threat of antimicrobial resistance and the need for increased government funding for basic research. A great read! @MoGen_Grad @researchuoft #supporthereport https://t.co/RxrET8HT3f
— Amanda Veri (@AmandaOVeri) February 10, 2018
Will Antimicrobial Stewardship Programs be the Next Target for De-implementation? https://t.co/Od5pk7rctx
— Eli Perencevich 😷 (@eliowa) February 28, 2018
Dr. John Lynch talks about why ID docs are best poised to lead antimicrobial stewardship programs. @Medscape https://t.co/L0kn2ORqy1
— IDSA (@IDSAInfo) February 17, 2018
If there were a vitamin or supplement that had 36% effectiveness in preventing influenza (including preventing some hospitalizations and deaths), people would be lining up to get it.https://t.co/H62IyV1uWN
— Paul Sax (@PaulSaxMD) February 15, 2018
According to the new systematic review published in @AJICJournal
— Antibiotic Steward (@ABsteward) February 20, 2018
There is no solid evidence that ASPs are effective in reducing antibiotic resistance in hospital settings. https://t.co/RVdmiksDpe pic.twitter.com/a5hNOYXUPX
The bacteria that causes #leprosy is mutating into something even more dangerous.
— Microbes&Infection (@MicrobesInfect) February 5, 2018
Genome analysis shows that some #Mycobacterium leprae strains becoming resistant to traditional drugs. https://t.co/gXMetRaYdp pic.twitter.com/EaYw6XMgcH
Why infectious disease physicians are best suited to lead antimicrobial stewardship efforts. https://t.co/r4BfjeXvfn
— IDSA (@IDSAInfo) February 13, 2018
Attention #healthcare professionals! @CDCgov launches online training course on antibiotic stewardship. Register: https://t.co/50HaLcN4Y7 #antibioticresistance pic.twitter.com/jERCMwrfyk
— Battle Superbugs (@battlesuperbugs) February 23, 2018
WHO's New Surveillance System Finds High Levels of #AntibioticResistance Worldwide, in high- and low-income countries alike.
— Microbes&Infection (@MicrobesInfect) February 3, 2018
E. coli, Klebsiella pneumoniae, Staphylococcus aureus, Streptococcus pneumoniae topped the list as most common resistant bacteriahttps://t.co/TjboLY93PC pic.twitter.com/dhhDAGOMRf
Antibiotic-resistant plasmids flourish in hospital plumbing - Study from @ASMicrobiology's @mbiojournal https://t.co/f924xOOITh pic.twitter.com/PXTJ1niFVR
— ASM Newsroom (@ASMnewsroom) February 6, 2018
'Intensive, well-resourced antibiotic stewardship found best in small hospitals - engaging ID docs & local pharmacists likely to be key' #StopSuperbugs #AMR https://t.co/s9tIXv735A
— Antibiotic Action (@TheUrgentNeed) February 25, 2018
We're hiring!
— AMR at Wellcome (@Wellcome_AMR) February 12, 2018
Interested in antimicrobial resistance and global health policy? Then come and join our growing team to shape our exciting international policy work on drug-resistant infections, and help us #StopSuperbugs https://t.co/nME5aQObNk
Really sensible, pragmatic approach to paediatric antimicrobial stewardship in this month's @ArchivesEandP - essential to adopt a patient centred approach; palatability & dosing frequency may outweigh strict use of narrow spectrum Abs https://t.co/BCeC7WAhq0 @ADC_BMJ @BSACandJAC
— Sanjay Patel (@doctorsanjay) February 4, 2018
#InfectiousDiseases A-Z: @WHO says poor vaccination rates may be the reason for the surge in #measles cases across #Europe. Dr. Pritish Tosh says, "Measles is among the most infectious agents we know," https://t.co/OgabWXWjkt pic.twitter.com/Nco7tYwD5Z
— Mayo Clinic (@MayoClinic) February 27, 2018
👾💉❤️
— Tim Gauthier (@IDstewardship) February 6, 2018
Got Enterococcus faecalis in the blood w/ infective #endocarditis? What should you treat with? This review helps differentiate the options & the evidence. 📲 https://t.co/RDQAXdLcJb w/ @Kerry_LaPlante pic.twitter.com/2wgIh9iDkm
Created by Cameron Forbes. Last updated November 10, 2019 at 15:41 EST.